Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
FDA approval for expanded use of BLINCYTO® in pediatric B-cell ALL by end of 2025?  | Binary | 3 | 15 days ago | ||
Amgen stock price increase by 10% post-ASH24 by January 8, 2025? | Binary | 3 | 15 days ago | ||
Major pharmaceutical partnership with Amgen for BLINCYTO® by mid-2025? | Binary | 3 | 15 days ago | ||
First region to approve BLINCYTO® for pediatric B-cell ALL post-ASH24 by end of 2025? | Categorical | 2 | 15 days ago | ||
BLINCYTO® sales growth in the first half of 2025? | Categorical | 2 | 15 days ago | ||
First major medical journal to feature AALL1731 trial results by March 2025? | Categorical | 2 | 15 days ago |